This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
Imperial Brands sees FY net revenues “at, or above” 1-4% guidance, on-track for FY targets. Tobacco growth modest, H2 offsetting H1 declines, but vols slightly behind last year. Next gen products YoY growth strong despite US regulatory uncertainty. Expects H1 profits to be hit by divestments (incl. Logista stake reduction). Sees 2% FX profit tailwinds in H1, no full-year FX impact.
Bellway H1 revs +12.4%, op. profit +8.7%, interim div +5%, net asset value +15.7%, return on capital -1.1pts, operating cash flow +18%; Reservations +2.8%, Completions +5.6%, Avg sale price +6.5%, fwd sales value -2.5%, fwd sales vol +4.3%; expects further growth in completions, but depends on Spring selling season; ongoing cost pressure of 3%, Brexit threat to material supply but working to mitigate.
Diploma H1 trading “robust” and in-line. Expects underlying revenues +5%, +10% at constant FX, of which 4% from acquisitions. Life Sciences revenues expected +5%, Seals +4%, Controls +8%.
Sports Direct considering 5p/share offer for Debenhams valuing it at £61.4m, a 127% premium to yesterday’s close. Pre-conditional on: 1) Ashley taking CEO position; 2) termination of noteholder consent solicitation for refinancing; 3) no new third-party secured funding arrangements; 4) no administration, CVA or insolvency process.
(Sources: Company newswires, Bloomberg, CNBC, FT, Reuters, Wall Street Journal)
For more information on any of these individual news items, call into the trading floor
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.Prepared by Michael van Dulken, Head of Research